2025-07-14

King-Friend will meet you in CPHI Malaysia！

Return

Previous NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing Next NKF makes its debut at CPHI Southeast Asia

Relevant recommendations

2025-10-21

NKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!
2025-10-17

NKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation
2025-08-04

NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
2025-07-21

NKF makes its debut at CPHI Southeast Asia
2025-06-09

NKF's subsidiary Kindos's Hydralazine Hydrochloride Injection gets FDA approval for marketing

Stock price

9.620

-0.020000000000001

©2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd苏ICP备13012010号